Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
2.130
+0.010 (0.47%)
At close: Nov 20, 2024, 4:00 PM
2.250
+0.120 (5.63%)
After-hours: Nov 20, 2024, 5:11 PM EST

Alaunos Therapeutics Revenue

Alaunos Therapeutics had revenue of $7.00K in the twelve months ending September 30, 2024, down -53.33% year-over-year. In the year 2023, Alaunos Therapeutics had annual revenue of $5.00K, down -99.83%.

Revenue (ttm)
$7.00K
Revenue Growth
-53.33%
P/S Ratio
n/a
Revenue / Employee
$7,000
Employees
1
Market Cap
3.41M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20235.00K-2.92M-99.83%
Dec 31, 20222.92M2.52M634.17%
Dec 31, 2021398.00K--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
NovaBay Pharmaceuticals 13.84M
China Pharma Holdings 5.54M
Oncternal Therapeutics 2.16M
Azitra 97.50K
Titan Pharmaceuticals 3.00K
Revenue Rankings